Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.56 |
| ▸ | CA1 | P00915 | 1/20 | 0.56 |
| ▸ | CA2 | P00918 | 1/20 | 0.56 |
| ▸ | CA9 | Q16790 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | MGAM | O43451 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | SI | P14410 | 1/20 | 0.39 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17577312 | 0.86 | CA12 (0.41) | CA12CA1CA2CA9LMNA | |
| SCHEMBL17665568 | 0.83 | LMNA (0.42) | CA12CA1CA2CA9LMNA | |
| SCHEMBL4123314 | 0.83 | MAPT (0.47) | CA12CA1CA2CA9LMNA | |
| SCHEMBL9641762 | 0.80 | CYP1A2 (0.43) | CA12CA1CA2CA9HSD17B10 | |
| SCHEMBL17242958 | 0.79 | CYP4F2 (0.44) | CA12CA1CA2CA9HSD17B10 | |
| SCHEMBL28332903 | 0.76 | POLB (0.37) | CA12CA1CA2CA9SMN1; SMN2 | |
| SCHEMBL5540795 | 0.75 | ALDH1A1 (0.33) | CA12CA1CA2CA9HSD17B10 | |
| SCHEMBL28856012 | 0.74 | HSD17B10 (0.50) | CA12CA1CA2CA9LMNA | |
| SCHEMBL7351851 | 0.74 | CA12 (0.32) | CA12CA1CA2CA9GAA | |
| Hydrochloric Acid SCHEMBL30428049 | 0.73 | CA12 (0.30) | CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 238 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117399072-A | Ultra-small cerium-based metal organic framework nano enzyme and preparation method and application thereof | 华南理工大学 | 2024-01-16 | — | — | CN | claimed |
| CN-117106189-A | Metal organic framework artificial hydrolase and preparation method and application thereof | 华南理工大学 | 2023-11-24 | — | — | CN | claimed |
| CN-114085193-A | Method for preparing 1H-tetrazoleacetic acid and derivatives thereof by aqueous phase method | 九江中星医药化工有限公司 | 2022-02-25 | — | — | CN | claimed |
| CN-111943899-A | Synthesis method of 5-ethyl formate tetrazole | 河北凯力昂生物科技有限公司 | 2020-11-17 | — | — | CN | claimed |
| US-10196604-B2 | Mitochondrial inhibitors for use in culturing pluripotent stem cells | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2019-02-05 | — | — | US | claimed |
| US-9918964-B2 | Reducing platelet activation, aggregation and platelet-stimulated thrombosis or blood coagulation by reducing mitochondrial respiration | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2018-03-20 | — | — | US | claimed |
| US-9691951-B2 | Curable silicone composition, and optical semiconductor device | DOW CORNING TORAY CO., LTD. (JP) | 2017-06-27 | — | — | US | claimed |
| US-20170130198-A1 | MITOCHONDRIAL INHIBITORS FOR USE IN CULTURING PLURIPOTENT STEM CELLS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2017-05-11 | — | — | US | claimed |
| US-20160233395-A1 | Curable Silicone Composition, And Optical Semiconductor Device | DOW TORAY CO., LTD. (JP) | 2016-08-11 | — | — | US | claimed |
| WO-2015196139-A1 | MITOCHONDRIAL INHIBITORS FOR USE IN CULTURING PLURIPOTENT STEM CELLS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2015-12-23 | — | — | WO | claimed |
| CN-103508970-B | A kind of production method of 5-tetrazoleacetic acid ethyl ester | HUAFENG CHEMICAL CO., LTD., NANTONG CITY (CN) | 2015-10-21 | — | — | CN | claimed |
| CN-103508970-A | Ethyl 1H-tetrazole-5-acetate production method | NANTONG HUAFENG CHEMICAL CO | 2014-01-15 | — | — | CN | claimed |
| CN-103508969-A | Synthesis production method of high-purity 1H-tetrazole-5-acetic acid | NANTONG HUAFENG CHEMICAL CO | 2014-01-15 | — | — | CN | claimed |
| CN-101993422-A | Synthesis and application of blue-fluorescence luminous cadmium metal complex | FUJIAN INST RES STR MATTER CAS | 2011-03-30 | — | — | CN | claimed |
| US-20090018123-A1 | Oxazolidinones Bearing Antimicrobial Activity Composition and Methods of Preparation | SINDKHEDKAR MILIND D | 2009-01-15 | — | — | US | claimed |
| EP-1912980-A2 | OXAZOLIDINONES BEARING ANTIMICROBIAL ACTIVITY COMPOSITION AND METHODS OF PREPARATION | Wockhardt Limited (IN) | 2008-04-23 | — | — | EP | claimed |
| WO-2007023507-A2 | OXAZOLIDINONES BEARING ANTIMICROBIAL ACTIVITY COMPOSITION AND METHODS OF PREPARATION | WOCKHARDT LIMITED (IN) | 2007-03-01 | — | — | WO | claimed |
| US-20260099093-A1 | PHOTOSENSITIVE RESIN COMPOSITION, METHOD FOR PRODUCING CURED RELIEF PATTERN USING SAME, AND METHOD FOR PRODUCING POLYIMIDE FILM USING SAME | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2026-04-09 | — | — | US | disclosed |
| US-4258195-A | Novel thiol esters and process for preparing cephalosporin compounds using same | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1981-03-24 | — | — | US | disclosed |
| EP-0004570-A1 | Thiol esters, process for their preparation, pharmaceutical compositions containing them and a process for preparing cephalosporin compounds using the same | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1979-10-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10196604-B2 | Mitochondrial inhibitors for use in culturing pluripotent stem cells | TFAM, TUFM, ALDH2 | CA12 3688/4885CA1 2182/4885CA2 1212/4885 |
| US-20260099093-A1 | PHOTOSENSITIVE RESIN COMPOSITION, METHOD FOR PRODUCING CURED RELIEF PATTERN USING SAME, AND METHOD FOR PRODUCING POLYIMIDE FILM USING SAME | CD79B, ITGA1, PTK2 | CA12 1676/4885CA1 204/4885CA2 833/4885 |
| US-20090018123-A1 | Oxazolidinones Bearing Antimicrobial Activity Composition and Methods of Preparation | POLL, POLM, POLRMT | CA12 3371/4885CA1 3004/4885CA2 3865/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.